HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Global Conference on Surgery and Anaesthesia

September 15-17, 2025 | Hybrid Event

September 15 -17, 2025 | London, UK
GCSA 2025

Observation of the clinical efficacy of robot assisted duodenum-preserving total pancreatic head resection in 21cases

Jun He, Speaker at Surgery Conferences
The First Affiliated Hospital of Soochow University, China
Title : Observation of the clinical efficacy of robot assisted duodenum-preserving total pancreatic head resection in 21cases

Abstract:

Short Description of what will be discussed during the presentation (about 250 - 500 words) Aims: To explore the treatment experience of robot assisted duodenum-preserving total pancreatic head resection (R-DPPHR) for benign and low-grade malignant diseases of the pancreatic head, including surgical indications, prevention and treatment of surgical complications, especially biliary complications. Method: A retrospective analysis was conducted on the case data of 21 patients who underwent R-DPPHR at the First Affiliated Hospital of Soochow University from February 2021 to May 2023. Results: A total of 21 cases in this group, including 12 males and 9 females, with an average age of 53.6 years. The average surgical time was 323 (241-401) minutes, the average intraoperative blood loss was 199 (80-500) mL, and the average postoperative hospital stay was 18.6 (10-30) days. Disease types: 3 cases of chronic mass pancreatitis, 8 cases of pancreatic neuroendocrine tumors, 2 cases of intraductal papilloma (IPMN), 5 cases of pancreatic serous cystadenoma, and 3 cases of pancreatic mucinous cyst The surgical methods are all robot assisted surgeries, with no surgical deaths After surgery, there were 7 cases of pancreatic fistula (all B-grade pancreatic fistula), 3 cases of biliary fistula, 1 case of common bile duct stenosis, 1 case of abdominal bleeding, 1 case of abdominal infection, and 2 cases of delayed gastric emptying. All patients were cured and discharged after non-surgical treatment 21 cases were followed up after surgery, with a follow-up period of 6 months to 2 years. There were no long-term complications such as recurrence, decreased endocrine function, delayed gastric emptying, and no deaths. Conclusion: Compared to previous DHHPR, R-DPPHR is an effective surgical approach for benign and lowgrade malignant diseases of the pancreatic head.

Biography:

He Jun studied Clinical Medicine at the Soochow University, Suzhou, China and graduated as MD in 2016. He then Started his career in the Department or General Surgery, The First Affiliated Hospital of Soochow University, as a Surgeon. He received a National Natural Science Foundation project in 2018. As a doctor, he is skilled in the diagnosis and treatment of liver, gallbladder, and pancreatic diseases. He has completed over 1000 cases of liver, gallbladder, and pancreatic surgeries, and has published more than 20 research articles in SCI (E) journals at the same time.

Watsapp